Gilad&Gilad Launches AgmaVet® For Horses for Promoting Resilient Nerve Functions and Joints Mobility

LAS VEGAS–(BUSINESS WIRE)–From the only company selling nutraceutical products containing the neuroprotective dietary ingredient G-Agmatine^®, Gilad&Gilad is excited to announce the launch of AgmaVet^® For Horses, a new product dedicated to promoting resilient nerve functions and alleviate joints discomfort.

Osteoarticular (OA), or joints, health deterioration is very common in animals, as it is in humans. It affects some 30-50% of dogs, cats and horses. In horses, its annual impact is as high as $1 billion.

Scientific evidence indicates that improper nerve functions underlie the tremendous discomfort caused by deteriorating OA health. This explains why existing treatments to maintain joint health are of limited effect and yield inconsistent results. “There is a clear unmet need for safe and effective natural dietary products that can relieve aches and leg weakness by promoting both resilient nerve functions and proper joints mobility,” said Dr. Gad M. Gilad, CEO of Gilad&Gilad.

Gilad&Gilad developed AgmaVet^® For Horses based on substantial scientific research and clinical trials. A recently published clinical trial has demonstrated that G-Agmatine^® can improve OA-associated lameness as well as protect horses from developing gastric ulcers, a serious side effect of existing treatments (J. Clin. Med. 2022, 11(24), 7283).

AgmaVet^® For Horses together with AgmaVet^® (for small animals) and AgmaSet^® belong to the Agmaceuticals^® line of patent protected products containing the neuroprotective ingredient G-Agmatine^®. These category-leading products are superior to existing therapies for sustaining resilient nerve functions and proper joints mobility.

You are Invited to upcoming showcases of AgmaVet^® For Horses:
– WVC Conference (February 16-18, 2026, in Las Vegas) – Booth #821
– Natural Product Expo West (March 16-18, 2026, in Anaheim) – Booth #3673

About Gilad&Gilad

Gilad&Gilad is a health science company with core competencies in Neuroscience, largely invested in R & D. The Company developed the exclusive Agmaceuticals^® product line based on its founders’ discovery of the neuroprotective properties of the natural molecule Agmatine. G-Agmatine^® is the best brand of premium grade agmatine. Agmatine usage for supporting nerve health and joint mobility is patented (US patents: 8,916,612; 9,585,852; 11,622,949; 11,877,990).

– For further information visit: https://ForNerveHealth.com, where you can download copies of relevant publications and a slide presentation.

– The Company seeks investments, distributors, and is open to acquisition or licensing inquiries.

Contacts

Gad M. Gilad, Ph.D.
Research, Gilad&Gilad LLC
1-702-233-5553
[e-mail]